Clinical trial • Phase I • Neurology
Clinical trial in Parkinson's disease
Phase I trial for Parkinson's disease. open-label, none/not specified-controlled. 40 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Parkinson's disease
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 22-05-2025
- First CTIS Authorization Date
- 22-08-2025
Trial design
open-label, none/not specified-controlled Phase I trial across 1 site in Hungary.
- Open Label
- Yes
- Comparator
- None/Not specified
- Target Sample Size
- 40
Recruitment
- Planned Sample Size
- 40
- Recruitment Window Months
- 11
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 40
Hungary
- Earliest CTIS Part Ii Submission Date
- 07-07-2025
- Latest Decision Or Authorization Date
- 10-12-2025
- Processing Time Days
- 156
- Number Of Sites
- 1
- Number Of Participants
- 40
Sites
- Site Name
- CRU Hungary Kft.
- Contact Person Name
- Géza LAKNER
- Contact Person Email
- glakner@cruint.com
- Number Of Participants
- 40
Sponsor
Primary sponsor
- Full Name
- Bial R&D Investments S.A.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Portugal
Related trials
Other published trials that may interest you.